Kehua Biotech: Announcement on the progress of the repurchase of shares held by minority shareholders by the holding subsidiary Technogenetics S.P.A.
Kehua Biotech: Announcement on investing in the establishment of a subsidiary
Kehua Biotech: Announcement of Resolutions of the 2024 Second Extraordinary General Meeting of Shareholders
Kehua Biotech: Legal Opinion of Beijing Jindu (Guangzhou) Law Firm on the 2024 Second Extraordinary General Meeting of Shareholders of Shanghai Kehua Bioengineering Co., Ltd.
Kehua Biotech: Notice on Convening the Second Extraordinary General Meeting of Shareholders in 2024
Kehua Biotech: Announcement on the signing of a quadripartite regulatory agreement to raise capital
Kehua Biotech: Announcement on convertible debt-for-equity swaps in the third quarter of 2024
Kehua Biotech: Announcement on Adding Implementing Entities, Implementation Locations, and Adjusting Investment Composition Details for Some Fund-raising Projects and Postponing Some Fund-raising Projects
Kehua Biotech: Announcement on the results of the resale of “Kehua Bonds Transfer”
Kehua Biotech: Announcement on the resumption of share conversion of “Kehua Bonds”
Kehua Biotech: The sixth indicative announcement on the resale of “Kehua Bonds Transfer”
Kehua Biotech: Fifth indicative announcement on the resale of “Kehua Bonds Transfer”
Kehua Biotech: Fourth indicative announcement on the resale of “Kehua Bonds Transfer”
Kehua Biotech: Third indicative announcement on the resale of “Kehua Bonds Transfer”
Kehua Biotech: Second indicative announcement on the resale of “Kehua Bonds Transfer”
Kehua Biotech: First indicative announcement on the resale of “Kehua Bonds Transfer”
Kehua Biotech: Inspection Opinions of CITIC Securities Co., Ltd. on matters relating to the resale of convertible corporate bonds of Shanghai Kehua Bioengineering Co., Ltd.
Kehua Biotech: Announcement on the suspension of share conversion of “Kehua Bonds” during the resale
Kehua Biotech: Announcement on the resale of “Kehua Bonds Transfer”
Kehua Biotech: Legal Opinion of Beijing Jindu (Guangzhou) Law Firm on the resale of convertible corporate bonds of Shanghai Kehua Biotechnology Co., Ltd.
No Data